18-10731430-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378183.1(PIEZO2):​c.5006G>A​(p.Arg1669Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,532,860 control chromosomes in the GnomAD database, including 50,996 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3597 hom., cov: 30)
Exomes 𝑓: 0.26 ( 47399 hom. )

Consequence

PIEZO2
NM_001378183.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.149

Publications

13 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004354328).
BP6
Variant 18-10731430-C-T is Benign according to our data. Variant chr18-10731430-C-T is described in ClinVar as Benign. ClinVar VariationId is 261511.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.269 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.5006G>A p.Arg1669Gln missense_variant Exon 36 of 56 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.5006G>A p.Arg1669Gln missense_variant Exon 36 of 56 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.204
AC:
30966
AN:
151460
Hom.:
3595
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0865
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.124
Gnomad SAS
AF:
0.211
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.229
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.204
GnomAD2 exomes
AF:
0.220
AC:
30682
AN:
139548
AF XY:
0.226
show subpopulations
Gnomad AFR exome
AF:
0.0785
Gnomad AMR exome
AF:
0.154
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.113
Gnomad FIN exome
AF:
0.255
Gnomad NFE exome
AF:
0.276
Gnomad OTH exome
AF:
0.231
GnomAD4 exome
AF:
0.257
AC:
355080
AN:
1381282
Hom.:
47399
Cov.:
32
AF XY:
0.257
AC XY:
175221
AN XY:
681710
show subpopulations
African (AFR)
AF:
0.0773
AC:
2427
AN:
31400
American (AMR)
AF:
0.159
AC:
5603
AN:
35288
Ashkenazi Jewish (ASJ)
AF:
0.242
AC:
6065
AN:
25108
East Asian (EAS)
AF:
0.135
AC:
4788
AN:
35516
South Asian (SAS)
AF:
0.225
AC:
17751
AN:
78922
European-Finnish (FIN)
AF:
0.254
AC:
8874
AN:
34920
Middle Eastern (MID)
AF:
0.259
AC:
1475
AN:
5686
European-Non Finnish (NFE)
AF:
0.273
AC:
294186
AN:
1076720
Other (OTH)
AF:
0.241
AC:
13911
AN:
57722
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
11557
23114
34670
46227
57784
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9772
19544
29316
39088
48860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.204
AC:
30959
AN:
151578
Hom.:
3597
Cov.:
30
AF XY:
0.203
AC XY:
15047
AN XY:
74062
show subpopulations
African (AFR)
AF:
0.0862
AC:
3568
AN:
41404
American (AMR)
AF:
0.193
AC:
2931
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
884
AN:
3466
East Asian (EAS)
AF:
0.125
AC:
640
AN:
5136
South Asian (SAS)
AF:
0.210
AC:
1012
AN:
4808
European-Finnish (FIN)
AF:
0.262
AC:
2725
AN:
10404
Middle Eastern (MID)
AF:
0.240
AC:
70
AN:
292
European-Non Finnish (NFE)
AF:
0.273
AC:
18500
AN:
67842
Other (OTH)
AF:
0.202
AC:
424
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1125
2249
3374
4498
5623
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.241
Hom.:
10303
Bravo
AF:
0.193
TwinsUK
AF:
0.258
AC:
957
ALSPAC
AF:
0.274
AC:
1057
ESP6500AA
AF:
0.103
AC:
143
ESP6500EA
AF:
0.279
AC:
889
ExAC
AF:
0.203
AC:
4574
Asia WGS
AF:
0.155
AC:
540
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
12
DANN
Benign
0.72
DEOGEN2
Benign
0.0034
.;T;.;T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.71
T;T;T;T
MetaRNN
Benign
0.0044
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;.;.;L
PhyloP100
-0.15
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.39
N;.;.;.
REVEL
Benign
0.042
Sift
Benign
0.35
T;.;.;.
Sift4G
Benign
0.55
T;T;T;T
Vest4
0.099
MPC
0.35
ClinPred
0.00049
T
GERP RS
2.6
Varity_R
0.014
gMVP
0.23
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2865121; hg19: chr18-10731428; COSMIC: COSV57440592; COSMIC: COSV57440592; API